BlackRock Investment Management’s Anika Therapeutics ANIK Stock Holding History

BlackRock Investment Management’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.78M	Buy	77,137 +13,336	+21%	+$617K	﹤0.01%	1782
2016 Q3	$3.05M	Sell	63,801 -106	-0.2%	-$5.24K	﹤0.01%	1838
2016 Q2	$3.43M	Buy	63,907 +3,568	+6%	+$168K	﹤0.01%	1706
2016 Q1	$2.7M	Buy	60,339 +951	+2%	+$38.6K	﹤0.01%	1789
2015 Q4	$2.27M	Buy	59,388 +352	+0.6%	+$13.5K	﹤0.01%	1986
2015 Q3	$1.88M	Sell	59,036 -554	-0.9%	-$19.3K	﹤0.01%	2116
2015 Q2	$1.97M	Buy	59,590 +8,994	+18%	+$321K	﹤0.01%	2246
2015 Q1	$2.08M	Buy	50,596 +727	+1%	+$29.4K	﹤0.01%	1992
2014 Q4	$2.03M	Sell	49,869 -266	-0.5%	-$10.4K	﹤0.01%	2027
2014 Q3	$1.84M	Buy	50,135 +1,949	+4%	+$84.2K	﹤0.01%	2063
2014 Q2	$2.23M	Buy	48,186 +5,539	+13%	+$246K	﹤0.01%	2001
2014 Q1	$1.75M	Buy	42,647 +237	+0.6%	+$8.81K	﹤0.01%	2130
2013 Q4	$1.62M	Buy	42,410 +5,354	+14%	+$165K	﹤0.01%	2170
2013 Q3	$885K	Buy	37,056 +930	+3%	+$20.9K	﹤0.01%	2536
2013 Q2	$614K	Buy	+36,126	New	+$521K	﹤0.01%	2717

Other funds holding ANIK

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Investment Management's ANIK Position: Q4 2016 in Review

BlackRock Investment Management increased its Anika Therapeutics (ANIK) stake by 21% in Q4 2016, buying an estimated $617K and bringing the position to 77,137 shares worth $3.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

BlackRock Investment Management first reported a position in ANIK in Q2 2013 and has held it in 15 quarters since. 158 funds tracked by Wall St. Rank hold ANIK as of Q4 2016.

BlackRock Investment Management held 77,137 shares of Anika Therapeutics worth $3.78M as of Q4 2016.
BlackRock Investment Management bought 13,336 Anika Therapeutics shares in Q4 2016, an estimated $617K.
Anika Therapeutics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1782 holding.
BlackRock Investment Management first reported a position in Anika Therapeutics in Q2 2013 and has held it in 15 quarters since.
158 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.